cystaran 0.44 % Ophthalmic Solution
- RxCUI
- 1313785
- RxNorm name
- cystaran 0.44 % Ophthalmic Solution
- Display name
- cystaran 0.44 % Ophthalmic Solution
- Full name
- cystaran 0.44 % Ophthalmic Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CYSTARAN | CYSTEAMINE HYDROCHLORIDE | Leadiant Biosciences, Inc. | b98ee838-ed23-42a9-93b5-72579e490fba | 2025-04-30 | Warnings, Adverse reactions | 1313785 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b98ee838-ed23-42a9-93b5-72579e490fba | cystaran 0.44 % Ophthalmic Solution [PSN] · cysteamine 4.4 MG/ML Ophthalmic Solution [Cystaran] [SBD] · Cystaran 0.44 % Ophthalmic Solution [SY] · Cystaran 4.4 MG/ML (cysteamine hydrochloride 6.5 MG/ML) Ophthalmic Solution [SY] · Cystaran 4.4 MG/ML Ophthalmic Solution [SY] | 5 | 23 | These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 1994 | 20250430 |